APA

Beumer J. H., Eiseman J. L., Parise R. A., Florian J. A., Joseph E., D'Argenio D. Z., Parker R. S., Kay B., Covey J. M. & Egorin M. J. (20080904). Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice. : Cancer chemotherapy and pharmacology.

Chicago

Beumer Jan H, Eiseman Julie L, Parise Robert A, Florian Jeffry A, Joseph Erin, D'Argenio David Z, Parker Robert S, Kay Brittany, Covey Joseph M and Egorin Merrill J. 20080904. Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice. : Cancer chemotherapy and pharmacology.

Harvard

Beumer J. H., Eiseman J. L., Parise R. A., Florian J. A., Joseph E., D'Argenio D. Z., Parker R. S., Kay B., Covey J. M. and Egorin M. J. (20080904). Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice. : Cancer chemotherapy and pharmacology.

MLA

Beumer Jan H, Eiseman Julie L, Parise Robert A, Florian Jeffry A, Joseph Erin, D'Argenio David Z, Parker Robert S, Kay Brittany, Covey Joseph M and Egorin Merrill J. Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice. : Cancer chemotherapy and pharmacology. 20080904.